Guse Kyle 4
4 · ATOSSA GENETICS INC · Filed Jun 29, 2018
Insider Transaction Report
Form 4
Guse Kyle
CFO & General Counsel
Transactions
- Award
Stock Option (right to buy)
2018-06-27+700,000→ 700,000 totalExercise: $2.38Exp: 2028-06-27→ Common Stock (700,000 underlying)
Footnotes (1)
- [F1]Twenty-five percent of the options have vested as of the grant date, 50% of the options will vest quarterly over two years, and the remaining 25% will vest upon achievement of certain milestones.